Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Biotechnology and pharmaceuticals
A biotech stock for investors who fear investing in the risky industry
Citigroup believes investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the…
Eli Lilly to build $6 billion manufacturing plant in Alabama
Eli Lilly CEO David A. Ricks speaks at a news conference at Generation Park in Houston, Monday, Sept. 23, 2025.…
RFK Jr. Vaccine Panel Postpones Vote on Infant Hepatitis B Vaccine
Health and Human Services Secretary Robert F. Kennedy Jr.'s hand-picked vaccine committee on Thursday postponed crucial votes on hepatitis B…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Access to abortion pill mifepristone holds steady under Trump, FDA review looms
Mifepristone and misoprostol pills are shown on Wednesday, Oct. 3, 2018, in Skokie, Illinois. Erin Hooley | Chicago Tribune |…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…
Novo Nordisk reduces Wegovy and Ozempic spot prices
Boxes of Ozempic and Wegovy manufactured by Novo Nordisk in a London pharmacy on March 8, 2024. Hollie Adams |…
Novo Nordisk pushes defense of its anti-obesity pill
A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, outside Copenhagen, Denmark, July 14, 2025.…
Omada Health will begin prescribing GLP-1 and other obesity medications
The Omada Health logo is displayed on the screen of a smartphone. soup images | Light rocket | fake images…